Uruganda rukora imiti rwa Changzhou,ishami rya Pharmaceutical Holdings ya Shanghai, yakiriye icyemezo cyo kwandikisha ibiyobyabwenge (Icyemezo No 2021S01077, 2021S01078, 2021S01079) cyatanzwe nubuyobozi bwa leta bushinzwe ibiyobyabwenge kuriLenalidomide Capsules(Ibisobanuro 5mg, 10mg, 25mg), byemejwe kubyara umusaruro.
Amakuru y'ibanze
Izina ry'ibiyobyabwenge:Ibikoresho bya Lenalidomide
Ifishi ikoreshwa:Capsule
Ibisobanuro:5mg, 10mg, 25mg
Ibyiciro byo kwiyandikisha:Imiti yimiti icyiciro cya 4
Umubare w'itsinda:Icyemezo cya Leta cyibiyobyabwenge H20213802, Icyemezo cyibiyobyabwenge cya leta H20213803, icyemezo cya leta cyibiyobyabwenge H20213804
Umwanzuro wo kwemeza: Uzuza ibisabwa kugirango umuntu yandike ibiyobyabwenge, yemejwe kwiyandikisha, atanga icyemezo cyo kwandikisha ibiyobyabwenge.
Ibisobanuro bijyanye
Lenalidomideni igisekuru gishya cyimiti ikingira umunwa hamwe numurimo wo kubuza ikwirakwizwa rya selile yibibyimba, gutera kanseri ya apoptose na immunomodulation, ikoreshwa cyane mukuvura myeloma nyinshi na syndrome ya myelodysplastic (MDS) nibindi bihe.Ikoreshwa ifatanije na dexamethasone kuvura abarwayi bakuze bafite myeloma myinshi itavuwe itari abakandida ba transplantation.Iki gicuruzwa gikoreshwa hamwe na dexamethasone mu kuvura abarwayi bakuze bafite myeloma nyinshi bakiriye byibuze imiti imwe ibanza.Iki gicuruzwa gikoreshwa hamwe na rituximab mu kuvura abarwayi bakuze barwaye lymphoma (icyiciro cya 1-3a) bakiriye mbere yo kuvurwa.
Lenalidomide capsules yatunganijwe bwa mbere na Celgene Biopharmaceuticals hanyuma igurishwa muri Amerika mu 2005. mu Kuboza 2019, Uruganda rwa Farumasi rwa Changzhou rwatanze icyifuzo cyo kwiyandikisha no kwamamaza mu kigo cya Leta gishinzwe ibiyobyabwenge ku biyobyabwenge, biremerwa.
Amakuru yo muri Minene.com yerekana ko igurishwa ryigihugu rya Nalidomide capsules muri 2020 rizaba hafi miliyari 1.025.
Dukurikije politiki y’igihugu ibishinzwe, ubwoko bw’ibiyobyabwenge rusange byemejwe hakurikijwe ibyiciro bishya byo kwiyandikisha bizahabwa inkunga nyinshi nko kwishyura ubwishingizi bw’ubuvuzi no gutanga amasoko y’ubuvuzi.Kubwibyo, umusaruro wemewe waUruganda rwa farumasi rwa Changzhou's lenalidomidecapsule ifasha kurushaho kwagura isoko ryayo mubijyanye no kuvura indwara ya hematologiya-ikibyimba no kuzamura isoko ryayo, ndetse no kwegeranya uburambe bwagaciro kubicuruzwa byakurikiyeho kugirango bikore neza muri rusange no kwandikisha dosiye.